Active

ARISTO PHARMA LIMITED Financials

Company number
09225220Copy
copy info iconCopy
Registered office
The North Suite Avro House, Lancaster Way Business Park, Ely CB6 3NW
Incorporated
18/09/2014

Company snapshot

Status
Active
Employees
0 (2025)
Latest financial data
2025
Accounts type
Small

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2025.

Net Assets

£338.13K2025
19.77%vs 2024

2024: £282.33K

Total Assets

£762.04K2025
-3.37%vs 2024

2024: £788.63K

Cash in Bank

£212.29K2025
-55.56%vs 2024

2024: £477.72K

Total Liabilities

£423.91K2025
-16.27%vs 2024

2024: £506.31K

Employees

02025
0vs 2024

2024: 0

In 2025, ARISTO PHARMA LIMITED reported net assets of £338.13K. The same filing shows total assets of £762.04K, cash in bank of £212.29K and total liabilities of £423.91K. Reported headcount was 0 in 2025. Cash in Bank fell from £477.72K in 2024 to £212.29K in 2025 (-55.56%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£338.13K2025
19.77%from £282.33K in 2024

Year-on-year change

Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.

3-year financial trend (2023–2025)

How the figures ARISTO PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.

Net Assets

£215.58K2023£338.13K2025
+56.8%vs 2023

+25.2% a year compound (CAGR)

Cash in Bank

£361.97K2023£212.29K2025
-41.4%vs 2023

-23.4% a year compound (CAGR)

Total Assets

£562.06K2023£762.04K2025
+35.6%vs 2023

+16.4% a year compound (CAGR)

Total Liabilities

£346.49K2023£423.91K2025
+22.3%vs 2023

+10.6% a year compound (CAGR)

Employees

4202302025
-100%vs 2023-4

Biggest increase

Net Assets+56.8%

£215.58K in 2023 to £338.13K in 2025

Biggest decrease

Employees-100%

4 in 2023 to 0 in 2025

ARISTO PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in net assets, pointing to a strengthening balance sheet, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.

Ratios from the filed figures

Calculated from ARISTO PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
44.37%2025

Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.

Liabilities to total assets
55.63%2025

Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.

Cash to liabilities
50.08%2025

Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.

Cash to total assets
27.86%2025

Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for ARISTO PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator20212022202320242025
Net Assets£102.21K154.12K215.58K282.33K338.13K
Total Assets£357.05K544.78K562.06K788.63K762.04K
Cash in Bank£176.21K334.04K361.97K477.72K212.29K
Total Liabilities£254.84K390.65K346.49K506.31K423.91K
Employees33400

ARISTO PHARMA LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Has ARISTO PHARMA LIMITED filed financial statements?

toggle

Yes. Okredo holds filed figures for ARISTO PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.

What net assets did ARISTO PHARMA LIMITED report in 2025?

toggle

ARISTO PHARMA LIMITED reported net assets of £338.13K for 2025. That compares with £282.33K in 2024, a change of 19.77%.

What total assets did ARISTO PHARMA LIMITED report in 2025?

toggle

ARISTO PHARMA LIMITED reported total assets of £762.04K for 2025. That compares with £788.63K in 2024, a change of -3.37%.

What cash in bank did ARISTO PHARMA LIMITED report in 2025?

toggle

ARISTO PHARMA LIMITED reported cash in bank of £212.29K for 2025. That compares with £477.72K in 2024, a change of -55.56%.

How many people does ARISTO PHARMA LIMITED employ?

toggle

ARISTO PHARMA LIMITED reported 0 employees in 2025, compared with 0 in 2024.

How have ARISTO PHARMA LIMITED financials changed over the last 3 years?

toggle

Between 2023 and 2025, ARISTO PHARMA LIMITED's net assets rose by 56.8%, cash in bank fell by 41.4%, total assets rose by 35.6% and total liabilities rose by 22.3%. Net assets compounded at 25.2% a year across the two years to 2025, from £215.58K to £338.13K. Reported headcount went from 4 in 2023 to 0 in 2025 (-4).

Which years of ARISTO PHARMA LIMITED financial data are available?

toggle

Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.